drugset / Trial / NCT02387450

Reduced Cardiovascular Morbi-mortality by Sildenafil in Patients With Arterial Claudication

NCT02387450

Phase 2/3 Unknown 400 enrolled University Hospital, Angers
RandomizedParallel-groupTriple-blindTreatment

Summary

Sildenafil has shown potential effects both on vasodilator mechanisms and as an inhibitor of the NO/GMPc Pain activation. The investigators aim at estimating the benefit of sildenafil in term of morbi-mortality in patients with arterial claudication on a multicenter prospective double blind study.

Timeline

Start
2015-09
Primary completion
2017-06
Completion
2017-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sildenafil Unknown 100 mg Oral